Nerpharma Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARMUSTINE DRUG SUBSTANCE, with a corresponding US DMF Number 32922.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 02, 2021, and payment made on September 23, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II